Johnson And Johnson's Revenue in the fiscal year 2025 $ 94,193.00 millions
Johnson And Johnson's Revenue in the fiscal year 2024 $ 88,821.00 millions
Johnson And Johnson's Revenue in the fiscal year 2023 $ 85,159.00 millions
Johnson And Johnson's Revenue in the fiscal year 2022 $ 94,943.00 millions
Johnson And Johnson's Revenue in the fiscal year 2021 $ 93,775.00 millions
JNJ Revenue second quarter 2026 Y/Y Growth Comment
Johnson and Johnson achieved in the second quarter 2026, above Company average Revenue improvement of 6.6% year on year, to $ 25,310.00 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 115 other companies have achieved higher Revenue growth. While Johnson And Johnson' s Revenue increase of 6.6% ranks overall at the positon no. 2403 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Johnson And Johnson's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
14.98 %
1 %
-16.37 %
JNJ's II. Quarter Q/Q Revenue Comment
Johnson and Johnson achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.19%, to $ 25,310.00 millions, from $24,062.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Johnson And Johnson's Revenue growth quarter on quarter, overall rank is 1130.
Johnson and Johnson achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.19%, to $ 25,310.00 millions, from $24,062.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Johnson And Johnson's Revenue growth quarter on quarter, overall rank is 1130.
Johnson And Johnson's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 28 2026)
12 Months Ending (Mar 29 2026)
12 Months Ending (Dec 28 2025)
12 Months Ending (Sep 28 2025)
12 Months Ending (Jun 29 2025)
Cumulative Revenue 12 Months Ending
$ 97,929.00
$ 96,362.00
$ 94,193.00
$ 92,149.00
$ 90,627.00
Y / Y Revenue Growth (TTM)
8.06 %
7.87 %
6.05 %
5.08 %
4.68 %
Year on Year Revenue Growth Overall
Ranking
# 2488
# 152
# 631
# 177
# 2751
Seqeuential Revenue Change (TTM)
1.63 %
2.3 %
2.22 %
1.68 %
1.45 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2403
# 147
# 500
# 1369
# 2351
Cumulative Revenue growth Comment
Johnson And Johnson saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 8.06% year on year, to $ 97,929 millions if the fiscal year would have ended in Jun 28 2026. Johnson And Johnson's trailing twelve months Revenue growth was higher than company's average 3.27% and higher than 7.87% growth in Mar 29 2026. But from twelve months ended Mar 29 2026 rise was beneth at 1.63 % from $96362 millions achieved in the period from Mar 29 2026 to Jun 29 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at3.27%. The momentum is even more impressive from twelve months ended Mar 29 2026 exhibited at 1.63 % increase from $96362 millions in the period from Mar 29 2026 to Jun 29 2025.
In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 152 to 2488.
Johnson And Johnson saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 8.06% year on year, to $ 97,929 millions if the fiscal year would have ended in Jun 28 2026. Johnson And Johnson's trailing twelve months Revenue growth was higher than company's average 3.27% and higher than 7.87% growth in Mar 29 2026. But from twelve months ended Mar 29 2026 rise was beneth at 1.63 % from $96362 millions achieved in the period from Mar 29 2026 to Jun 29 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at3.27%. The momentum is even more impressive from twelve months ended Mar 29 2026 exhibited at 1.63 % increase from $96362 millions in the period from Mar 29 2026 to Jun 29 2025.
In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 152 to 2488.
About Johnson And Johnson Revenue Growth Rates (JNJ), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.50%